Using quantitative proteomics, Westbrook et al. discovered that the expression of CAPG and GIPC1 in the bone metastatic variant of human breast cancer cell line MDA-MB-231 was higher than in the parental non-bone metastatic cells. Here, GIPC1 is linked to breast cancer.